Wolverine Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Wolverine Trading’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-21,732	Closed	-$74K	–	5875
2018 Q3	$74K	Buy	+21,732	New	+$78.4K	﹤0.01%	4626
2017 Q4	–	Sell	-46,677	Closed	-$257K	–	5875
2017 Q3	$331K	Sell	46,677 -11,281	-19%	-$81.1K	﹤0.01%	3127
2017 Q2	$408K	Buy	+57,958	New	+$362K	﹤0.01%	2645
2016 Q4	–	Sell	-33,016	Closed	-$170K	–	5571
2016 Q3	$170K	Sell	33,016 -94,944	-74%	-$512K	﹤0.01%	3928
2016 Q2	$865K	Buy	+127,960	New	+$715K	﹤0.01%	1718

Wolverine Trading's KERX Position: Q4 2018 in Review

Wolverine Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 21,732 shares — an estimated $74K sold.

Wolverine Trading first reported a position in KERX in Q2 2016 and held it in 5 quarters. The position peaked at $865K in Q2 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Wolverine Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Wolverine Trading sold 21,732 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $74K.
Wolverine Trading first reported a position in Keryx Biopharmaceuticals Inc in Q2 2016 and held it in 5 quarters.
Wolverine Trading's Keryx Biopharmaceuticals Inc position peaked at $865K in Q2 2016.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Wolverine Trading's 13F filing for Q4 2018, filed 14 Feb 2019.